Literature DB >> 7536258

Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate.

C J Girman1, S J Jacobsen, H A Guess, J E Oesterling, C G Chute, L A Panser, M M Lieber.   

Abstract

We describe relationships among symptoms, prostate volume and peak urinary flow rate in an age stratified, community based random sample of white men 40 to 79 years old with no prior prostate surgery, prostate cancer or other conditions known to interfere with voiding. Symptoms were assessed with an instrument comparable to the American Urological Association symptom index. Prostate volume was estimated by transrectal ultrasonography and peak urinary flow rate was measured by a portable device. Subject age was significantly associated with symptom score but accounted for only 3% of its variation, while prostate volume and peak urinary flow rate explained only an additional 10% of the symptom variability. The odds (95% confidence interval) of moderate to severe symptoms increased with age from 1.9 (1.1 to 3.1), 2.9 (1.7 to 5.0) and 3.4 (1.8 to 6.1) for men 50 to 59, 60 to 69 and 70 to 79 years old, respectively, relative to men 40 to 49 years old. Adjusting for age, the odds of moderate to severe symptoms were 3.5 times greater for men with prostatic enlargement (more than 50 ml.) than for men with smaller prostates, while the odds were similarly increased (2.4-fold) for men not achieving a peak urinary flow rate of 10 ml. per second. Estimated odds changed little when other cutoff points were considered for peak urinary flow rate (15 ml. per second) or prostate volume (40 ml.). These results, based on randomly selected white men, suggest a somewhat stronger, albeit modest, relationship among symptoms, prostate size and urinary flow rate than previously reported in clinic based studies. The strength of these relationships is comparable to that found with other diseases.

Entities:  

Mesh:

Year:  1995        PMID: 7536258     DOI: 10.1016/s0022-5347(01)67448-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  43 in total

Review 1.  Update on the medical management of benign prostatic hyperplasia.

Authors:  Manoj Monga
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 2.  The role of 5-alpha-reductase inhibition as monotherapy in view of the MTOPS data.

Authors:  Jaspreet S Sandhu; Alexis E Te
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

3.  Correlation between the total volume, transitional zone volume of the prostate, transitional prostate zone index and lower urinary tract symptoms (LUTS).

Authors:  Mario Franciosi; Walter José Koff; Ernani Luis Rhoden
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

4.  Effect of prostatitis on lower urinary tract symptoms: retrospective analysis of prostate biopsy tissue.

Authors:  Jai Hyun Chung; Ji Hyeong Yu; Luck Hee Sung; Chung Hee Noh; Jae Yong Chung
Journal:  Korean J Urol       Date:  2012-02-20

5.  Safety and feasibility of concomitant surgery during holmium laser enucleation of the prostate (HoLEP).

Authors:  Amar Patel; Rafael Nunez; Chinedu O Mmeje; Mitchell R Humphreys
Journal:  World J Urol       Date:  2014-02-06       Impact factor: 4.226

6.  Duration of urination does not change with body size.

Authors:  Patricia J Yang; Jonathan Pham; Jerome Choo; David L Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-26       Impact factor: 11.205

7.  Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.

Authors:  Jennifer L St Sauver; Michael M Lieber; Susan L Slager; Debra J Jacobson; Michaela E McGree; Steven J Jacobsen
Journal:  BJU Int       Date:  2011-04-11       Impact factor: 5.588

8.  Lack of association between the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene polymorphism and the risk of benign prostatic hyperplasia in Caucasian men.

Authors:  Anastasios Karatzas; Vassilios Tzortzis; Eirini Giannatou; Stavros Gravas; Ioannis Zachos; Athanassios Oeconomou; Michael Melekos; Aspasia Tsezou
Journal:  Mol Biol Rep       Date:  2013-09-21       Impact factor: 2.316

Review 9.  Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?

Authors:  Granville L Lloyd; Jeffrey M Marks; William A Ricke
Journal:  Curr Urol Rep       Date:  2019-08-03       Impact factor: 3.092

10.  Intravesical prostatic protrusion in men in Olmsted County, Minnesota.

Authors:  Michael M Lieber; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Cynthia J Girman; Steven J Jacobsen
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.